The proposed role of protein kinases and potassium channels in the signal transduction pathway by which microbial metabolites decrease severity of myocardial infarction has been based on experiments with kinase inhibitors, compounds that stop one kinase activating another, and potassium channel blockers applied at conventional inhibitory concentrations. The gene discussed is WEE1; the disease is myocardial infarction.